Hongene is thrilled to announce our participation in OTS 2024. The Oligonucleotide Therapeutics Society (OTS) Annual Meeting is a forum for the realization of the Society’s mission and goals, to foster academic and industry-based research for development.
Welcome to visit our booth at #4-11. Let’s discuss how Hongene’s high-quality nucleic acid products and end-to-end RNA medicines solution can help make your project successful.
Featured Talk Session
Speaker: David Butler, Chief Technology Officer
Title: The Evolving Landscape of Oligonuecleotide Manufacturing
Date/Time: Sunday, October 6, 09:55 -10:20 a.m. EDT
Overview: The presentation emphasizes the ongoing innovation in scalable manufacturing technologies to meet the growing demand for RNA therapeutics, while addressing the product purity and environmental challenges associated with current methods.
Watch the on-demand video to explore more!